BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18088046)

  • 1. [Diabetic cardiomyopathy: old disease or new entity?].
    Seferović PM; Lalić NM; Seferović JP; Jotić A; Lalić K; Ristić AD; Simeunović D; Radovanović G; Vujisić-Tesić B; Ostajić MU
    Srp Arh Celok Lek; 2007; 135(9-10):576-82. PubMed ID: 18088046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cardiomyopathy: ongoing controversies in 2012.
    Seferović PM; Milinković I; Ristić AD; Seferović Mitrović JP; Lalić K; Jotić A; Kanjuh V; Lalić N; Maisch B
    Herz; 2012 Dec; 37(8):880-6. PubMed ID: 23223771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy.
    Lebeche D; Davidoff AJ; Hajjar RJ
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):715-24. PubMed ID: 18813212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart disease and diabetes: from pathophysiology to therapeutic options].
    Fragasso G; Palloshi A; Bassanelli G; Steggerda R; Montano C; Margonato A
    Ital Heart J; 2004 Mar; 5 Suppl 2():4S-15S. PubMed ID: 15074772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.
    Home PD; Pacini G
    Diabetes Obes Metab; 2008 Sep; 10(9):699-718. PubMed ID: 17825080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
    Codinach Huix P; Freixa Pamias R
    An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic heart disease.
    Marwick TH
    Heart; 2006 Mar; 92(3):296-300. PubMed ID: 16159978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure in diabetes mellitus: causal and treatment considerations.
    Sander GE; Wilklow FE; Giles TD
    Minerva Cardioangiol; 2004 Dec; 52(6):491-503. PubMed ID: 15729210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic heart disease.
    Marwick TH
    Postgrad Med J; 2008 Apr; 84(990):188-92. PubMed ID: 18424575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure and diabetes.
    Bala C; Hâncu N
    Rom J Intern Med; 2004; 42(2):267-75. PubMed ID: 15529617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic cardiomyopathy].
    Cohen A
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):479-86. PubMed ID: 7646266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.
    Tousoulis D; Tsarpalis K; Cokkinos D; Stefanadis C
    Diabetes Obes Metab; 2008 Sep; 10(10):834-42. PubMed ID: 18034844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options.
    Mytas DZ; Stougiannos PN; Zairis MN; Foussas SG; Pyrgakis VN; Kyriazis IA
    J Diabetes Complications; 2009; 23(4):273-82. PubMed ID: 18413201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.
    Aneja A; Tang WH; Bansilal S; Garcia MJ; Farkouh ME
    Am J Med; 2008 Sep; 121(9):748-57. PubMed ID: 18724960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
    Fang ZY; Prins JB; Marwick TH
    Endocr Rev; 2004 Aug; 25(4):543-67. PubMed ID: 15294881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
    Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
    Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic cardiomyopathy: the search for a unifying hypothesis.
    Poornima IG; Parikh P; Shannon RP
    Circ Res; 2006 Mar; 98(5):596-605. PubMed ID: 16543510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.